Bundle and Save—FREE Shipping on Orders Over $100

Menu
Tesamorelin Peptide – COA Verified GHRH Analog for Growth Hormone and Metabolic Research | Not Labs
, ,

Tesamorelin Peptide (5mg / 10mg)

Price range: $48.00 through $78.00 Free U.S. shipping on $100+

Tesamorelin peptide (5mg, 10mg) — COA-verified GHRH analog studied for its effects on growth hormone release, metabolic regulation, and body composition pathways. High-purity, research-only compound from Not Labs.

Out of Stock

Overview

Tesamorelin peptide is a synthetic analog of growth hormone–releasing hormone (GHRH) designed to stimulate growth hormone secretion in laboratory research models. Researchers have studied Tesamorelin peptide for its ability to influence metabolic regulation, body composition, and growth factor pathways, making it a valuable compound in metabolic and endocrine investigations.

Compound Breakdown

Tesamorelin modifies the GHRH structure to improve stability and enhance biological activity in experimental systems. By binding to the GHRH receptor, it triggers the release of growth hormone (GH), which in turn influences insulin-like growth factor 1 (IGF-1) production. These downstream effects have been explored in research contexts examining muscle metabolism, adipose tissue regulation, and hormonal signaling.

Key findings from preclinical and investigational research include:

  • Growth Hormone Secretion: Tesamorelin peptide has been shown to stimulate GH release in controlled models.

  • Metabolic Regulation: Research suggests Tesamorelin may influence lipid metabolism and visceral adipose tissue pathways.

  • IGF-1 Stimulation: Increased IGF-1 levels have been observed in response to Tesamorelin in investigational studies.

  • Stability: Tesamorelin’s modified structure improves half-life, making it more effective than native GHRH for sustained GH release.

Research Applications

Tesamorelin peptide has been evaluated across several laboratory research areas:

  • Endocrine Studies: Investigating its effects on the hypothalamic-pituitary axis and growth hormone dynamics.

  • Metabolic Research: Studied for its potential to modulate lipid metabolism and insulin sensitivity in controlled models.

  • Body Composition: Evaluated in research settings focused on visceral adiposity, muscle-to-fat ratios, and related biomarkers.

  • Aging Research: Growth hormone decline is a hallmark of aging, and Tesamorelin provides a model compound for studying GH replacement pathways.

These findings remain limited to research environments and are not indicative of clinical or therapeutic outcomes.

Related Categories

Tesamorelin is included in the Hormone Compounds category, where it is often studied with CJC-1295 No DAC and Ipamorelin for investigations into growth hormone modulation.

Compliance Statement

All Not Labs products are provided strictly for laboratory research use only. Tesamorelin peptide is not approved for human or veterinary use.

Certificate of Analysis

FAQ

  • How does Tesamorelin peptide differ from natural GHRH?
    Tesamorelin is a stabilized analog of GHRH, designed to enhance half-life and potency, allowing researchers to study more sustained growth hormone release in experimental models.

  • What are the primary research areas for Tesamorelin?
    Research focuses include growth hormone secretion, IGF-1 pathways, lipid metabolism, and body composition regulation.

  • How stable is Tesamorelin peptide in laboratory storage?
    Lyophilized Tesamorelin peptide is typically stored at -20°C. After reconstitution, stability may be maintained under refrigeration for several weeks when aliquoted properly.

  • What effects on IGF-1 have been reported in research?
    Studies have observed elevated IGF-1 levels following Tesamorelin administration in preclinical and investigational settings, highlighting its role in growth factor pathways.

  • How does Tesamorelin contribute to metabolic research?
    Tesamorelin has been investigated for its ability to reduce visceral adipose tissue and regulate lipid metabolism, making it useful in metabolic and obesity-related studies.

  • Why do researchers choose Not Labs Tesamorelin?
    Not Labs provides COA-verified Tesamorelin peptide at industry-leading pricing, ensuring researchers have access to reliable, high-purity compounds for endocrine and metabolic investigations.

References

References:

  1. Falutz J, et al. (2009). Tesamorelin, a growth hormone releasing factor analogue, in the treatment of HIV-associated lipodystrophy. Expert Opinion on Investigational Drugs. Taylor & Francis
  2. Stanley TL, et al. (2021). Effects of tesamorelin on nonalcoholic fatty liver disease in people with HIV. Journal of Clinical Endocrinology & Metabolism. PubMed
  3. Allas S, et al. (2014). Long-term safety of tesamorelin treatment in HIV-infected patients with abdominal fat accumulation. Journal of the International AIDS Society. PubMed
  4. Falutz J, et al. (2017). Tesamorelin decreases visceral fat and maintains reductions over 2 years in HIV-infected patients with abdominal fat accumulation. AIDS. PubMed

Reviews

There are no reviews yet.

Be the first to review “Tesamorelin Peptide (5mg / 10mg)”

Your email address will not be published. Required fields are marked *

Related products

Log in

Sign up
Sign up

We're launching soon!

Be first in line. Get exclusive launch access and a members-only offer.